CIT GAP Funds Invests in Jeeva to Decentralize and Improve Clinical Trial Operations
Summary
The Center for Innovative Technology (CIT) today announced that CIT GAP Funds has invested in Herndon, Va.-based Jeeva Informatics Solutions Inc. (Jeeva), a precision medicine data science company focused on significantly accelerating clinical trial operations by taking trials to patients’ homes. “Accelerating the process of clinical research will bring critical, innovative treatments to market that we have lacked for decades,” said Harsha Rajasimha, Founder and CEO of Jeeva. Our unique solution will enable communities living in rural, mountains, and hard-to-reach remote locations to participate in late stage clinical trials. Jeeva has successfully delivered BioHealthIT solutions to customers including the Catholic Health Initiatives, Morehouse School of Medicine, and Lockheed Martin. Jeeva successfully completed the nationally competitive NSF I-Corps program following several hundred discovery interviews with key stakeholders in 2019 to lead the life science industry transformation with a focus on patients and sponsors.